Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromazepam-induced dystonia.

J M Pérez Trullen, P J Modrego Pardo, M Vázquez André

    Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
    |January 1, 1992
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myotonic dystrophy type 1: 13 years of experience at a tertiary hospital. Clinical and epidemiological study and genotype-phenotype correlation.

    Neurologia·2023
    Same author

    Myotonic dystrophy type1: 13years of experience at a tertiary hospital. Clinical and epidemiological study and genotype-phenotype correlation.

    Neurologia·2021
    Same author

    Amyotrophic neuralgia of atypical presentation associated with exposure to a hepatitis B vaccine.

    Neurologia·2018
    Same author

    Trends in stroke hospitalisation rates and in-hospital mortality in Aragon, 1998-2010.

    Neurologia·2016
    Same author

    [Neuroprotection in Parkinson's disease: analysis though group of experts' methodology].

    Neurologia (Barcelona, Spain)·2009
    Same author

    The Spanish school of neurology and the first American cases of Alzheimer's disease.

    Journal of the history of the neurosciences·2004

    Bromazepam, a benzodiazepine, can paradoxically cause oromandibular dystonia, a rare side effect. This case highlights the potential for these widely used anxiety medications to induce extrapyramidal symptoms.

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Clinical Neurology

    Background:

    • Benzodiazepines are commonly prescribed for anxiety disorders.
    • Extrapyramidal side effects are uncommon with benzodiazepine use.
    • Diazepam is known to treat certain drug-induced movement disorders.

    Observation:

    • A case of a patient developing oromandibular dystonia is presented.
    • The patient had recently taken Bromazepam, a benzodiazepine medication.
    • Oromandibular dystonia is a movement disorder affecting the jaw and mouth muscles.

    Findings:

    • Bromazepam, despite its general safety profile, was associated with the onset of oromandibular dystonia in this patient.
    • This finding contrasts with the typical use of benzodiazepines and their known side effect profile.

    Related Experiment Videos

  • The study explores potential neurobiological mechanisms underlying drug-induced dystonia.

    • Implications:

    • Clinicians should be aware of the rare possibility of benzodiazepine-induced dystonia, even with drugs known for good tolerance.
    • Further research into the mechanisms of drug-induced movement disorders is warranted.
    • This case contributes to understanding the complex relationship between benzodiazepines and extrapyramidal symptoms.